Binding Truths: Seronegative anti-GBM disease mediated by IgM anti-GBM antibodies
暂无分享,去创建一个
[1] Bicheng Liu,et al. Clinical relevance of glomerular IgM deposition in patients with lupus nephritis , 2021, BMC immunology.
[2] A. Salama,et al. Binding Truths: Atypical Anti−Glomerular Basement Membrane Disease Mediated by IgA Anti−Glomerular Basement Membrane Antibodies Targeting the α1 Chain of Type IV Collagen , 2018, Kidney international reports.
[3] S. Nasr,et al. The clinicopathologic characteristics and outcome of atypical anti-glomerular basement membrane nephritis. , 2016, Kidney international.
[4] J. Thurman,et al. IgM exacerbates glomerular disease progression in complement induced glomerulopathy , 2015, Kidney international.
[5] Jinan Li,et al. Blockade of self-reactive IgM significantly reduces injury in a murine model of acute myocardial infarction. , 2010, Cardiovascular research.
[6] E. Neilson,et al. Molecular architecture of the Goodpasture autoantigen in anti-GBM nephritis. , 2010, The New England journal of medicine.
[7] Yong-Beom Park,et al. IgM Antibodies to Apoptosis-Associated Determinants Recruit C1q and Enhance Dendritic Cell Phagocytosis of Apoptotic Cells1 , 2009, The Journal of Immunology.
[8] C. Pusey,et al. Retransplantation in Alport post-transplant anti-GBM disease. , 2004, Kidney international.
[9] A. Rees,et al. Molecular cloning of the human Goodpasture antigen demonstrates it to be the alpha 3 chain of type IV collagen. , 1992, The Journal of clinical investigation.